Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REVELUTION
NCT05320406Phase 2Active, not recruiting
- Sponsor
- Emory University
- Start
- Jun 2022
- Primary completion
- Jan 2025
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of tissue-plasminogen activator in prostate cancer (PCa), sponsored by Emory University. Started Jun 2022; status: active, not recruiting.
02
Drugs
tissue-plasminogen activator
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT05320406.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05320406.